Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001481512-15-000002
Filing Date
2015-07-23
Accepted
2015-07-23 14:29:25
Documents
1
Effectiveness Date
2015-07-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9733
  Complete submission text file 0001481512-15-000002.txt   10803
Mailing Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

EIN.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-244331 | Film No.: 151002058